| Size | Price | Stock | Qty |
|---|---|---|---|
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
| Targets |
Not applicable. 2,6-Dimethoxyphenol-d3 is not a pharmacologically active drug; it is an analytical standard. Its "target" is the analytical measurement process. In research contexts, the unlabeled compound (2,6-dimethoxyphenol) is a substrate for the enzyme laccase, a copper-containing oxidase, and also exhibits antioxidant properties by scavenging free radicals. The d3-labeled version is used purely for quantitation.
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
In vitro, the unlabeled 2,6-dimethoxyphenol is widely utilized as a chromogenic substrate for measuring laccase activity. When oxidized by laccase, it forms colored products that can be monitored spectrophotometrically. Additionally, the unlabeled compound demonstrates antioxidant activity by scavenging free radicals. The d3-labeled version has no biological activity and is solely an analytical standard. |
| ln Vivo |
Not applicable (no in vivo biological activity). 2,6-Dimethoxyphenol-d3 is not intended for in vivo pharmacological studies. It is a stable isotope-labeled analytical standard used exclusively for quantitative analysis in complex biological matrices. The unlabeled compound has been studied in the context of enzymatic polymerization to synthesize dimers with high antioxidant capacity, but the d3-labeled version itself is not administered to living organisms.
|
| Enzyme Assay |
Not applicable. As an analytical standard, 2,6-Dimethoxyphenol-d3 is used in HPLC or LC-MS/MS methods for quantitation. A typical non-cellular workflow involves: preparing the d3-labeled compound as an internal standard; adding it to biological or food samples; extracting the analyte using appropriate solvents (e.g., organic extraction); separating by reversed-phase chromatography; and detecting by mass spectrometry using selected reaction monitoring (SRM), where the d3-labeled standard provides correction for matrix effects and extraction efficiency.
|
| Cell Assay |
Not applicable. 2,6-Dimethoxyphenol-d3 is not used in cell-based assays for pharmacological purposes. It is an analytical standard used in sample preparation workflows rather than in live cell experiments. If a cell-based assay were to be performed with the unlabeled compound, it would involve treating cell cultures to measure laccase-like activity or antioxidant capacity, but this is not standard for the d3-labeled version.
|
| Animal Protocol |
Not applicable. 2,6-Dimethoxyphenol-d3 is not used in animal experiments. It is strictly a research-grade analytical standard for in vitro analysis. No protocols exist for administering this deuterium-labeled compound to animals for pharmacokinetic or efficacy studies. The compound's application is limited to laboratory-based quantitative analysis of laccase activity or as an internal standard in various analytical chemistry workflows.
|
| ADME/Pharmacokinetics |
Not applicable. 2,6-Dimethoxyphenol-d3 is not a drug candidate. Therefore, no pharmacokinetic parameters are reported. The compound is supplied as a solid powder, stable for up to 3 years when stored at -20degC and for up to 2 years at 4degC. It is stable at ambient temperature for several days during ordinary shipping. For storage, it should be kept in a cool, dry place away from light.
|
| Toxicity/Toxicokinetics |
Not applicable. Toxicity studies are not performed for analytical reference standards like 2,6-Dimethoxyphenol-d3, as it is not intended for human consumption or therapeutic use. The unlabeled compound (2,6-dimethoxyphenol) may cause skin and eye irritation and is harmful if swallowed. Standard laboratory safety precautions should be taken, including the use of personal protective equipment and handling in a well-ventilated area.
|
| References |
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
[2]. Oluyemisi E. et al. Enzymatic modification of 2,6-dimethoxyphenol for the synthesis of dimers with high antioxidant capacity. Process biochemistry, 47, 1926-1932. |
| Additional Infomation |
2,6-Dimethoxyphenol-d3 is a stable isotope-labeled internal standard used in mass spectrometry and NMR applications. It is not a drug and has no approved therapeutic indications. The unlabeled compound (2,6-Dimethoxyphenol) is a phenolic compound known for its laccase substrate activity and antioxidant properties. It has been investigated for enzymatic synthesis of dimers with high antioxidant capacity. The d3-labeled version is exclusively an analytical tool for quantitative studies.
|
| Molecular Formula |
C8H10O3
|
|---|---|
| Molecular Weight |
154.163202762604
|
| Exact Mass |
157.081
|
| CAS # |
2484091-60-1
|
| Related CAS # |
2,6-Dimethoxyphenol;91-10-1
|
| PubChem CID |
129719595
|
| Appearance |
Typically exists as solid at room temperature
|
| LogP |
1.1
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
11
|
| Complexity |
104
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[2H]C1=C(C(=C(C(=C1[2H])OC)O)OC)[2H]
|
| InChi Key |
KLIDCXVFHGNTTM-QGZYMEECSA-N
|
| InChi Code |
InChI=1S/C8H10O3/c1-10-6-4-3-5-7(11-2)8(6)9/h3-5,9H,1-2H3/i3D,4D,5D
|
| Chemical Name |
3,4,5-trideuterio-2,6-dimethoxyphenol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.4868 mL | 32.4338 mL | 64.8677 mL | |
| 5 mM | 1.2974 mL | 6.4868 mL | 12.9735 mL | |
| 10 mM | 0.6487 mL | 3.2434 mL | 6.4868 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
